Research And Development
Health
Manufacturing

ACADIA Pharmaceuticals

$29.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.59 (2.03%) Today
$0.00 (0.00%) As of 4:32 PM EDT after-hours

Why Robinhood?

You can buy or sell ACAD and other stocks, options, ETFs, and crypto commission-free!

About ACAD

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. Read More The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Employees
430
Headquarters
San Diego, California
Founded
1993
Market Cap
4.28B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.41M
High Today
$29.85
Low Today
$29.22
Open Price
$29.32
Volume
1.04M
52 Week High
$30.38
52 Week Low
$12.86

Collections

Research And Development
Health
Manufacturing
Pharmaceutical
Technology
Medical
Biotechnology

ACAD News

ReutersAug 2

Edited Transcript of ACAD earnings conference call or presentation 31-Jul-19 8:30pm GMT

52

ACAD Earnings

-$0.59
-$0.52
-$0.45
-$0.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 5, After Hours

Popular Stocks

More ACAD News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.